Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Cancer Treatment Reviews|January 23, 2026
Insights into RAS-driven melanoma and its therapeutic implicationsEftychia Chatziioannou, Konstantinos Lallas, Tobias Sinnberg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 25, 2025
Psychosocial distress and persistent adverse events in long-term survivors of stage IV melanoma - a cross-sectional questionnaire studyMarkus Reitmajer, Norbert Schäffeler, Anne Bach, et al.
Journal of Virology|September 16, 2011
Cross-species analysis of the replication complex of Old World arenaviruses reveals two nucleoprotein sites involved in L protein functionRomy Kerber, Toni Rieger, Carola Busch, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2010
Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppressionAndreas Bergthaler, Lukas Flatz, Ahmed N Hegazy, et al.
Frontiers in Oncology|May 19, 2023
Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case reportSelina Reiter, Christopher Schroeder, Julian Broche, et al.
Therapeutic Advances in Medical Oncology|April 2, 2025
Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2Markus Reitmajer, Lena Nanz, Nina Müller, et al.
Pigment Cell & Melanoma Research|July 20, 2023
Histopathologic abundance of pigmentation correlates with disease-specific survival in malignant melanoma but is not independent of current AJCC pT stageValentin Aebischer, Amar Abu-Ghazaleh, Gisela Metzler, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumabStefan Diem, Sabine Schmid, Mirjam Krapf, et al.
International Immunology|June 30, 2010
Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypesDaniel D Pinschewer, Lukas Flatz, Ralf Steinborn, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitisPhilippe Cottagnoud, Marc Pfister, Fernando Acosta, et al.
Pageof 13